- Home
- DC vs CYRX Comparison
DC vs CYRX Comparison
Compare DC & CYRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | DC | CYRX |
|---|---|---|
| Founded | 2017 | 1999 |
| Country | United States | United States |
| Employees | N/A | 1100 |
| Industry | Precious Metals | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 783.6M | 814.9M |
| IPO Year | 2022 | 2008 |
Fundamental Metrics
Financial Performance| Metric | DC | CYRX |
|---|---|---|
| Price | $5.82 | $15.55 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 4 | 8 |
| Target Price | $9.48 | ★ $13.31 |
| AVG Volume (30 Days) | ★ 1.2M | 426.2K |
| Earning Date | 05-08-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 27.03 | ★ 156.22 |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $176,177,000.00 |
| Revenue This Year | N/A | $11.06 |
| Revenue Next Year | N/A | $8.45 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $3.79 | $7.61 |
| 52 Week High | $7.25 | $17.20 |
Technical Indicators
Market Signals| Indicator | DC | CYRX |
|---|---|---|
| Relative Strength Index (RSI) | 51.97 | 43.67 |
| Support Level | $5.79 | $14.55 |
| Resistance Level | $5.98 | $15.60 |
| Average True Range (ATR) | 0.26 | 0.64 |
| MACD | -0.08 | -0.13 |
| Stochastic Oscillator | 29.54 | 24.52 |
Price Performance
Historical ComparisonAbout DC Dakota Gold Corp.
Dakota Gold Corp is a gold exploration and development company focused on revitalizing the Homestake District in Lead, South Dakota. The company holds gold mineral properties surrounding the historic Homestake Mine and is advancing key projects, including the Richmond Hill Project.
About CYRX CryoPort Inc.
CryoPort Inc is a provider of integrated, temperature-controlled supply chain solutions for the life sciences industry, with a focus on supporting the cell and gene therapy market. The company provides services such as temperature-controlled logistics, biostorage, bioservices, cryopreservation solutions, and cryogenic systems manufacturing. It operates through two reportable segments: Life Sciences Services and Life Sciences Products. It generates the majority of its revenue from the Life Sciences Services segment.